|By PR Newswire||
|August 25, 2014 03:07 PM EDT||
ST. JAMES, N.Y., Aug. 25, 2014 /PRNewswire/ -- Gyrodyne Company of America, Inc. (NASDAQ: GYRO) (the "Company") today announced that the Company's Special Meeting of Shareholders, originally scheduled for Thursday, August 14, 2014, and previously postponed to Wednesday, August 27, 2014, has been further postponed. The Company now intends to hold the Special Meeting coextensively with the Company's 2014 Annual Meeting of Shareholders, the date and time for which will be will be announced, together with a new record date for shareholders entitled to vote at the Special Meeting, in the next few weeks.
The further postponement of the Special Meeting was necessary because the Company has yet to receive either the majority needed for a quorum or the vote of two-thirds of the outstanding shares of the Company's common stock needed to authorize the previously announced merger transaction, under which the Company and Gyrodyne Special Distribution, LLC will merge into Gyrodyne, LLC.
Frederick C. Braun III, the Company's President and Chief Executive Officer, said "Even though in our board's view the consummation of the merger transaction provides great benefits to our shareholders, it is a very complex transaction. While over 99% of the votes received to date are in favor of the proposal to approve the merger transaction, we simply have not yet received a sufficient number of votes. With many of our shareholders enjoying vacation during the Summer months and with our shareholder base having become far more diversified and numerous than our historical base, we believe shareholders require additional time. Postponement will permit us to continue to communicate with our shareholders and the investment community as to the merits of the merger."
About Gyrodyne Company of America, Inc.
Gyrodyne, a real estate investment trust, manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties primarily in the New York metropolitan area. Gyrodyne owns a 68 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of development plans. Gyrodyne also owns medical office buildings in Port Jefferson Station, New York, Cortlandt Manor, New York and Fairfax, Virginia. Gyrodyne is also a limited partner in Callery Judge Grove, L.P., the only assets of which consist of potential future payments upon the achievement of certain development benchmarks by the purchaser in the 2013 sale by the partnership of an undeveloped 3,700 plus acre property in Palm Beach County, Florida. The Company's common stock is traded on the NASDAQ Stock Market under the symbol GYRO. Additional information about Gyrodyne may be found on its web site at www.gyrodyne.com.
Forward-Looking Statement Safe Harbor
The statements made in this press release that are not historical facts constitute "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995, and Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, both as amended, which can be identified by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "projects," "estimates," "believes," "seeks," "could," "should," or "continue," the negative thereof, other variations or comparable terminology as well as statements regarding the evaluation of strategic alternatives. Important factors, including certain risks and uncertainties, with respect to such forward-looking statements that could cause actual results to differ materially from those reflected in such forward-looking statements include, but are not limited to, risks associated with Gyrodyne's ability to implement the tax liquidation, plan of liquidation or the plan of merger, the risk that the proceeds from the sale of Gyrodyne's assets may be substantially below Gyrodyne's estimates, the risk that the proceeds from the sale of our assets may not be sufficient to satisfy Gyrodyne's obligations to its current and future creditors, the risk of shareholder litigation against the tax liquidation, the plan of liquidation or the plan of merger and other unforeseeable expenses related to the proposed liquidation, the tax treatment of condemnation proceeds, the effect of economic and business conditions, including risks inherent in the real estate markets of Suffolk and Westchester Counties in New York, Palm Beach County in Florida and Fairfax County in Virginia, risks and uncertainties relating to developing Gyrodyne's undeveloped property in St. James, New York and other risks detailed from time to time in Gyrodyne's SEC reports.
Important Information for Investors and Shareholders
This communication does not constitute a solicitation of any vote or approval. The plan of merger will be submitted to Gyrodyne's shareholders for their consideration and vote at the special meeting. INVESTORS AND SHAREHOLDERS ARE ADVISED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND RELATED DOCUMENTS CAREFULLY (WHEN THEY BECOME AVAILABLE) AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The Joint Proxy Statement/Prospectus and other documents containing other important information about Gyrodyne and Gyrodyne, LLC filed or furnished to the SEC (when they become available) may be read and copied at the SEC's public reference room located at 100 F Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Rooms may be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website, www.sec.gov, from which any electronic filings made by Gyrodyne or Gyrodyne, LLC may be obtained without charge. In addition, investors and shareholders may obtain copies of the documents filed with or furnished to the SEC upon oral or written request without charge. Requests may be made in writing by regular mail by contacting Gyrodyne at the following address: One Flowerfield, Suite 24, St. James, NY 11780, Attention: Investor Relations. The Joint Proxy Statement/Prospectus also is available on Gyrodyne's web site located at www.gyrodyne.com.
Gyrodyne and its directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies in respect of the transaction. Information regarding Gyrodyne's directors and executive officers and their ownership of Gyrodyne's common stock is available in the Joint Proxy Statement/Prospectus. Other information regarding the interests of such individuals as well as information regarding Gyrodyne's directors and officers is available in the Joint Proxy Statement/Prospectus. These documents can be obtained free of charge from the sources indicated above.
SOURCE Gyrodyne Company of America, Inc.
Sep. 25, 2016 03:15 PM EDT Reads: 4,365
Sep. 25, 2016 03:00 PM EDT Reads: 1,537
Sep. 25, 2016 02:45 PM EDT Reads: 2,459
Sep. 25, 2016 02:30 PM EDT Reads: 2,296
Sep. 25, 2016 02:30 PM EDT Reads: 1,505
Sep. 25, 2016 02:15 PM EDT Reads: 1,791
Sep. 25, 2016 02:00 PM EDT Reads: 2,576
Sep. 25, 2016 02:00 PM EDT Reads: 1,510
Sep. 25, 2016 01:00 PM EDT Reads: 819
Sep. 25, 2016 12:45 PM EDT Reads: 2,419
Sep. 25, 2016 12:15 PM EDT Reads: 1,091
Sep. 25, 2016 12:15 PM EDT Reads: 3,374
Sep. 25, 2016 11:45 AM EDT Reads: 1,640
Sep. 25, 2016 11:30 AM EDT Reads: 1,508
Sep. 25, 2016 11:00 AM EDT Reads: 1,564